Table 2.
Distribution of sociodemographic and clinical characteristics of people with an HCV notification across different periods of time to treatment initiation in NSW 2016–2018 (N = 3925).
| Characteristics | Total ⸙ | DAA Treatment Initiation | Never DAA Treated n (%) ** |
|||
|---|---|---|---|---|---|---|
| N (%) § | Ever DAA Treated n (%) ** | DAA Initiation ≤ 6 Months n (%) ** |
DAA Initiation > 6 Months n (%) ** |
|||
| Total | 3925 (100) | 2372 (60) | 1370 (35) | 1002 (26) | 1553 (40) | |
| Age at HCV Diagnosis * | ≤ 29 | 802 (20) | 426 (53) | 191 (24) | 235 (29) | 376 (47) |
| 30–44 | 1424 (36) | 828 (58) | 448 (32) | 380 (27) | 596 (42) | |
| 45–59 | 1199 (31) | 792 (66) | 494 (41) | 298 (25) | 407 (34) | |
| ≥ 60 | 499 (13) | 326 (65) | 237 (48) | 89 (18) | 173 (35) | |
| Sex | Male | 2729 (70) | 1763 (65) | 1029 (38) | 734 (27) | 966 (35) |
| Female | 1196 (31) | 609 (51) | 341 (29) | 268 (22) | 587 (49) | |
| Aboriginal Ethnicity * | No | 2633 (67) | 1702 (65) | 1007 (38) | 695 (26) | 931 (35) |
| Yes | 766 (20) | 376 (49) | 170 (22) | 206 (27) | 390 (51) | |
| Country of Birth * | Australia | 2890 (74) | 1809 (63) | 1016 (35) | 793 (27) | 1081 (37) |
| Overseas | 582 (15) | 328 (56) | 199 (34) | 129 (22) | 254 (44) | |
| Co-Infection Status | HCV only | 3792 (97) | 2292 (60) | 1319 (35) | 973 (26) | 1500 (40) |
| HCV/HBV | 66 (2) | 28 (42) | 13 (20) | 15 (23) | 38 (58) | |
| HCV/HIV | 66 (2) | 52 (79) | 38 (58) | 14 (21) | 14 (21) | |
| Area of Residence at The Time of HCV * | Metro | 759 (19) | 439 (58) | 304 (40) | 135 (18) | 320 (42) |
| Outer Metro | 1079 (28) | 649 (60) | 356 (33) | 293 (27) | 430 (40) | |
| Rural/regional | 1775 (45) | 1121 (63) | 633 (36) | 488 (28) | 654 (37) | |
| Time to RNA Test | < 1 week | 1689 (43) | 1160 (69) | 806 (48) | 354 (21) | 529 (31) |
| 1–4 weeks | 411 (11) | 304 (74) | 187 (46) | 117 (29) | 107 (26) | |
| > 4 weeks | 834 (21) | 583 (70) | 227 (27) | 356 (43) | 251 (30) | |
| No test recorded | 991 (25) | 325 (33) | 150 (15) | 175 (18) | 666 (67) | |
| Incarcerated | No history | 2463 (63) | 1494 (61) | 948 (39) | 546 (22) | 969 (39) |
| Distant | 580 (15) | 348 (60) | 182 (31) | 166 (29) | 232 (40) | |
| Recent | 882 (23) | 530 (60) | 240 (27) | 290 (33) | 352 (40) | |
| Drug Dependence | No history | 2170 (55) | 1316 (61) | 850 (39) | 466 (22) | 854 (39) |
| Distant | 473 (12) | 303 (64) | 178 (38) | 125 (26) | 170 (36) | |
| Recent | 1282 (33) | 753 (59) | 342 (27) | 411 (32) | 529 (41) | |
| History of AUD | No history | 3598 (92) | 2152 (60) | 1266 (35) | 886 (25) | 1446 (40) |
| History | 327 (8) | 220 (67) | 104 (32) | 116 (36) | 107 (33) | |
| History of ESLD | No history | 3834 (98) | 2318 (61) | 1340 (35) | 978 (26) | 1516 (40) |
| History | 91 (2) | 54 (59) | 30 (33) | 24 (26) | 37 (41) | |
* Missing data not shown, AUD = alcohol use disorder, ESLD = end-stage liver disease, ⸙ Total HCV notifications weighted to adjust for the sex-specific spontaneous viral clearance, § column percentage, ** row percentage.